Back to Search
SIDNEY COHEN, M.D.
M.D.
Gastroenterology Physician
NPI: 1821057720Individual
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
MD011317E(PA)
Research & Publications (20)
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer.
PMID 19282466·Ann Oncol·2009
8-other
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
PMID 18591556·J Clin Oncol·2008
4-observational
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.
PMID 18665076·Pancreas·2008
8-other
Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors.
PMID 18376220·Am J Clin Oncol·2008
3-trial
Rotator cuff contusions of the shoulder in professional football players: epidemiology and magnetic resonance imaging findings.
PMID 17158276·Am J Sports Med·2007
8-other
Allograft safety in anterior cruciate ligament reconstruction.
PMID 17920955·Clin Sports Med·2007
6-review
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
PMID 16945168·Clin Colorectal Cancer·2006
8-other
Novel targets in pancreatic cancer: focus on future paths to therapy.
PMID 16981833·Expert Opin Ther Targets·2006
7-preclinical
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282.
PMID 16029791·Int J Radiat Oncol Biol Phys·2005
3-trial
Targeting signal transduction pathways in colorectal cancer--more than skin deep.
PMID 15998904·J Clin Oncol·2005
6-review
Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer.
PMID 14760509·Cancer Chemother Pharmacol·2004
3-trial
Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma.
PMID 12663718·J Clin Oncol·2003
3-trial
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002.
PMID 12447289·Gastrointest Endosc·2002
6-review
Drug development in pancreatic cancer: finally, biology begets therapy.
PMID 12794245·Int J Gastrointest Cancer·2002
6-review
Phase I and pharmacokinetic study of once daily oral administration of S-1 in patients with advanced cancer.
PMID 12114411·Clin Cancer Res·2002
3-trial
An enhanced 13-week bioassay: an alternative to the 2-year bioassay to screen for human carcinogenesis.
PMID 19616417·Exp Toxicol Pathol·2010
7-preclinical
Metal atom dynamics in four triferrocenylmethane derivatives and the crystal structure of Fc3COH.
PMID 19672505·Dalton Trans·2009
8-other
Methyl jasmonate: a plant stress hormone as an anti-cancer drug.
PMID 19660769·Phytochemistry·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 132 S 10TH ST, 480 MAIN BUILDING
PHILA, PA 19107 - Phone
- (215) 955-8900
Quick Facts
- NPI
- 1821057720
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile